Live feed
Filing
SC 13D/A
SC 13D/A0001299265-16-000008·NAVIDEA BIOPHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
NEOPROBE CORP
Security class unavailable · CUSIP: 640518106
Event date: 2016-06-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 13,964,519
- Percent of class
- 8.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001299265-16-000008
- Form type
- SC 13D/A
- Filer
- NAVIDEA BIOPHARMACEUTICALS, INC.
- CIK
- CIK 810509
- Filed
- Jun 28, 2016
- Reporting period
- Jun 14, 2016
- Description
- Schedule 13D beneficial ownership